Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghav Sundar

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Scientific Reports|January 19, 2022
Distinct spatio-temporal and spectral brain patterns for different thermal stimuli perceptionZied Tayeb, Andrei Dragomir, Jin Ho Lee, et al.
International Journal of Cancer|February 26, 2021
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancerJia Li Low, Yiqing Huang, Kenneth Sooi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trialsAlvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2018
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trialsTerri Patricia McVeigh, Raghav Sundar, Nikolaos Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysisAlberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal AdenocarcinomaJoseph J Zhao, Dominic Wei Ting Yap, Yiong Huak Chan, et al.
NPJ Digital Medicine|August 27, 2024
Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.
Liver Cancer|March 6, 2023
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-AnalysisKhi Yung Fong, Joseph Jonathan Zhao, Rehena Sultana, et al.
Frontiers in Oncology|January 24, 2022
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral NeuropathyAlisha Joan Leen, Dominic Wei Ting Yap, Chong Boon Teo, et al.
BMC Cancer|March 9, 2021
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Scientific Reports|January 19, 2022
Distinct spatio-temporal and spectral brain patterns for different thermal stimuli perceptionZied Tayeb, Andrei Dragomir, Jin Ho Lee, et al.
International Journal of Cancer|February 26, 2021
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancerJia Li Low, Yiqing Huang, Kenneth Sooi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trialsAlvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2018
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trialsTerri Patricia McVeigh, Raghav Sundar, Nikolaos Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysisAlberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal AdenocarcinomaJoseph J Zhao, Dominic Wei Ting Yap, Yiong Huak Chan, et al.
NPJ Digital Medicine|August 27, 2024
Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.
Liver Cancer|March 6, 2023
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-AnalysisKhi Yung Fong, Joseph Jonathan Zhao, Rehena Sultana, et al.
Frontiers in Oncology|January 24, 2022
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral NeuropathyAlisha Joan Leen, Dominic Wei Ting Yap, Chong Boon Teo, et al.
BMC Cancer|March 9, 2021
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Pageof 15